Medical Device | Healthcare | Biotechnology | Pharmaceuticals

The bioburden testing market is witnessing growth due to factors such as growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination are expected to drive the growth of this market during the forecast period. Bioburden Testing Market Dynamics: Impact Analysis 1. Geographical Snapshot of the Bioburden Testing Market 2. Growth Opportunities in Emerging Economies 3. Growth in the Medical Devices, Pharmaceutical, and Biotechnology Sector 4. Safety Concerns Related to Food and Beverage Products 5. Increasing Food Imports Into the US The bioburden testing market to grow from USD 1.10 billion by 2023 from USD 0.61 billion in 2018, at a Compound Annual Growth Rate (CAGR) of 12.4% Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global Bioburden Testing market? 2. What are the drivers, r...

The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination. Raw material testing to account for the largest share of the bioburden testing applications market Based on application, the  bioburden testing market  is segmented into raw material testing, medical device testing, in-process material testing, sterilization validation testing, and equipment cleaning validation. The raw material testing segment is expected to account for the largest market share in 2018. The large share of this segment can be attributed to the rising quality standards in manufacturing to avoid consequences such as contaminations ...